Position in CYTK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$58,702,469
+$2,390,679 QoQ
Shares Held
689,077
-19.3% QoQ
Ownership
0.496%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#48
of 477 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $3,275,701,264 across 414 Biotechnology names. CYTK ranks #14 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
4,377,120 | $306,529,713 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
399,847 | $249,320,598 | |
| 3 | ARGX |
Argenx SE
|
157,958 | $146,548,693 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
262,258 | $130,271,416 | |
| 5 | BNTX |
BioNTech SE
|
1,319,517 | $122,781,056 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
552,710 | $103,511,528 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
1,079,015 | $102,689,857 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,155,442 | $86,057,320 |
All Filings in CYTK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,702,469 | 689,077 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $56,311,790 | 854,374 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $36,844,431 | 579,862 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $13,600,676 | 247,465 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9,589,694 | 290,245 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,549,063 | 237,598 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,159,394 | 24,647 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,127,417 | 40,292 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,029,799 | 55,921 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $12,027,440 | 171,551 | Shares | Defined | 2024-05-01 | |
| 2023-09-30 | $3,028,635 | 102,805 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,825,056 | 55,949 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $2,805,628 | 79,728 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,459,159 | 53,670 | Shares | Defined | 2023-02-14 | |
| 2022-06-30 | $2,388,478 | 60,791 | Shares | Defined | 2022-08-12 | |
| 2021-12-31 | $8,693,929 | 190,740 | Shares | Defined | 2022-02-09 | |
| 2021-06-30 | $666,250 | 33,666 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $465,362 | 20,007 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $197,804 | 9,519 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $364,672 | 16,844 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $151,649 | 6,434 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $2,460,407 | 208,686 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||